BioNJ Welcomes Randi Bromberg as Vice President, Communications and Marketing

TRENTON, NJ (November 13, 2015) — BioNJ, the trade association for New Jersey’s life sciences industry, announced that Randi Bromberg joined the organization as Vice President, Communications and Marketing. Randi brings more than 25 years of experience, including managing media relations and writing and executing forward-thinking marketing strategies and initiatives that foster member engagement, build… Read the full article



BioNJ Thanks Our Renewing Members:

BioNJ thanks our renewing Preferred Members: EisnerAmper, LLP EisnerAmper’s Life Sciences Practice professionals have the expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. In addition to the traditional tax and accounting services, Amper also assists our life sciences clients with services spanning the… Read the full article


BioNJ welcomes our new Associate Members

BioNJ welcomes our new Associate Members: Borderless Executive Search, Inc. Borderless Executive Search, Inc. is an international executive search and leadership consulting firm specializing in life sciences (pharma, biotech and medtech). Founded in 2000, we take an innovative, consultative and seamless approach to trans-national executive search. We operate as one global team, working across cultures… Read the full article


BioNJ welcomes our new Innovation Members

BioNJ welcomes our new Innovation Members: Acuta Pharmaceuticals, LLC Aucta Pharmaceuticals, LLC is founded by experienced pharmaceutical research scientists from the U.S. and China, and managed by U.S. pharma industry veterans, with locations in Shanghai, China and New Jersey. Our expertise is new drug product development, product label improvement and solving difficult technical issues. We… Read the full article


Celator® Pharmaceuticals Announces VYXEOS™ (CPX -351) Shows No QT/QTc Interval Prolongation in an Intensive QT/QTc Study

Accepted for presentation at the upcoming American Society of Hematology (ASH) Annual Meeting EWING, N.J., Oct. 21, 2015 — Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that a Phase 2 pharmacokinetic and pharmacodynamics (PK/PD) study evaluating the effects of VYXEOS™ (CP-X351) on cardiac depolarization/repolarization has concluded and VYXEOS did not prolong the QT/QTc interval. This… Read the full article


BioNJ’s Inaugural Inspiring Women in STEM Conference

BioNJ’s Inaugural Inspiring Women in STEM Conference A Day of Inspiration, Learning and Professional Growth Trenton, NJ (October 21, 2015) – BioNJ’s inaugural Inspiring Women in STEM Conference, scheduled for Friday, December 4 at Sanofi, Bridgewater, NJ, will bring together professionals of all levels from the STEM community for an empowering professional development program. Through forward-thinking presentations,… Read the full article


Celator® Pharmaceuticals Announces Positive Recommendation From Data And Safety Monitoring Board For Phase 3 Study Of CPX-351

Celator® Pharmaceuticals Announces Positive Recommendation From Data And Safety Monitoring Board For Phase 3 Study Of CPX-351 (VYXEOS™) – Company expects Overall Survival Data in First Quarter of 2016 – EWING, N.J., Oct. 19, 2015 /PRNewswire/ — Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) today announced that the independent Data and Safety Monitoring Board (DSMB) for the Company’s Phase 3… Read the full article


BioNJ welcomes our new Institutional Members

BioNJ welcomes our new Institutional Member: Cambridge Crystallographic Data Centre The Cambridge Crystallographic Data Centre (CCDC) is a crystallographic organization based in Cambridge, England. It is a non-profit organization whose primary role is the compilation and maintenance of the Cambridge Structural Database, a database of small molecule crystal structures. We also perform analysis on the… Read the full article